STOCK TITAN
  1. Home
  2. Sec-filings
  3. ROIV
  4. [Form 4] Roivant Sciences Ltd. Insider Trading Activity

Roivant Sciences (ROIV) director-linked entity reports 1.44M-share open-market sale

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Roivant Sciences Ltd. reported insider-related share sales linked to an investment entity associated with director Daniel Allen Gold. QVT Financial Investment Cayman Ltd. completed open-market sales of a total of 1,438,163 common shares of Roivant Sciences over three days, at prices between $33.92 and $35.28 per share. After the most recent transaction, QVT Financial Investment Cayman Ltd. held 13,689,166 common shares indirectly. Gold is one of three directors of QVT Financial Investment Cayman Ltd., shares voting and investment control over these shares, and disclaims beneficial ownership except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Director‑linked entity reported multi-day open‑market sales while retaining a large remaining position.

The filing shows QVT Financial Investment Cayman Ltd., an entity associated with director Daniel Allen Gold, executed open-market sales of Roivant Sciences common shares across three days, totaling 1,438,163 shares. Sale prices ranged from $33.92 to $35.28 per share.

Following these transactions, the entity still held 13,689,166 common shares indirectly. The footnote explains that Gold is one of three directors of QVT Financial Investment Cayman Ltd., shares voting and investment control, and disclaims beneficial ownership except for his pecuniary interest. These are discretionary open-market sales, not option exercises or tax withholdings.

Insider Gold Daniel Allen
Role null
Sold 1,438,163 shs ($49.35M)
Type Security Shares Price Value
Sale Common Shares 12,380 $35.28 $437K
Sale Common Shares 200,000 $34.44 $6.89M
Sale Common Shares 600,000 $34.59 $20.75M
Sale Common Shares 300,783 $33.92 $10.20M
Sale Common Shares 325,000 $34.07 $11.07M
Holdings After Transaction: Common Shares — 13,689,166 shares (Indirect, Held by QVT Financial Investment Cayman Ltd.)
Footnotes (1)
  1. [object Object]
Total shares sold 1,438,163 shares Net open-market sales across reported transactions
Shares held after latest sale 13,689,166 shares Indirect holdings by QVT Financial Investment Cayman Ltd. after June 30, 2026
June 30, 2026 sale 12,380 shares at $35.28/share Open-market sale of common shares
June 29, 2026 sales (trade 1) 600,000 shares at $34.59/share Open-market sale of common shares
June 29, 2026 sales (trade 2) 200,000 shares at $34.44/share Open-market sale of common shares
June 26, 2026 sales (trade 1) 325,000 shares at $34.07/share Open-market sale of common shares
June 26, 2026 sales (trade 2) 300,783 shares at $33.92/share Open-market sale of common shares
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect financial
"ownership_type: "indirect"; nature_of_ownership: "Held by QVT Financial Investment Cayman Ltd.""
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
beneficial ownership financial
"shall not be deemed an admission of beneficial ownership of all of the reported Common Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gold Daniel Allen
(Last)(First)(Middle)
C/O ROIVANT SCIENCES LTD.
7TH FLOOR, 50 BROADWAY
(Street)
LONDONX0SW1H 0DB
(City)(State)(Zip)
UNITED KINGDOM
(Country)		2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares06/26/2026S300,783D$33.9214,826,546I(1)Held by QVT Financial Investment Cayman Ltd.
Common Shares06/26/2026S325,000D$34.0714,501,546I(1)Held by QVT Financial Investment Cayman Ltd.
Common Shares06/29/2026S200,000D$34.4414,301,546I(1)Held by QVT Financial Investment Cayman Ltd.
Common Shares06/29/2026S600,000D$34.5913,701,546I(1)Held by QVT Financial Investment Cayman Ltd.
Common Shares06/30/2026S12,380D$35.2813,689,166I(1)Held by QVT Financial Investment Cayman Ltd.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
/s/ Dan Gold06/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

Who conducted the recent share sales reported for Roivant Sciences (ROIV)?

The reported sales were conducted by QVT Financial Investment Cayman Ltd., an entity associated with director Daniel Allen Gold. Gold is one of three directors of this entity and shares voting and investment control, while disclaiming beneficial ownership except for his pecuniary interest.

How many Roivant Sciences (ROIV) shares were sold in the latest Form 4?

The filing reports open-market sales totaling 1,438,163 common shares of Roivant Sciences Ltd. These sales occurred across three transactions days and reflect net selling activity, as summarized in the transaction data within the filing’s transactionSummary section.

Over what dates did QVT Financial Investment Cayman Ltd. sell Roivant Sciences (ROIV) shares?

The open-market sales of Roivant Sciences common shares occurred on June 26, June 29, and June 30, 2026. Multiple transactions were executed on June 26 and June 29, followed by a smaller sale on June 30, according to the detailed transaction records.

What prices were the Roivant Sciences (ROIV) shares sold for in this Form 4?

The reported open-market sales were executed at prices between $33.92 and $35.28 per share. Individual transactions occurred at $33.92, $34.07, $34.44, $34.59, and $35.28 per share, as specified for each sale in the filing’s transaction table.

How many Roivant Sciences (ROIV) shares does the reporting entity hold after the sales?

After the most recent reported transaction, QVT Financial Investment Cayman Ltd. held 13,689,166 Roivant Sciences common shares indirectly. This post-transaction holding reflects the position remaining after completing all the reported open-market sales in the filing.

Does Daniel Allen Gold claim full beneficial ownership of the Roivant Sciences (ROIV) shares?

No. The footnote states that Daniel Allen Gold disclaims beneficial ownership of the Roivant Sciences shares held by QVT Financial Investment Cayman Ltd., except to the extent of his pecuniary interest, and that reporting them does not constitute an admission of beneficial ownership.